Innoviva (INVA) Cash from Investing Activities Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 116.52% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 38.24% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -22.09% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 30.54% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | 44.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 44.80% |
| Sep 30, 2025 | 32.98% |
| Jun 30, 2025 | 147.35% |
| Mar 31, 2025 | 37.67% |
| Sep 30, 2024 | -40.26% |
| Mar 31, 2024 | -17.70% |
| Sep 30, 2023 | -93.53% |
| Mar 31, 2023 | -61.68% |
| Sep 30, 2022 | -44.37% |
| Jun 30, 2022 | -28.57% |
| Mar 31, 2022 | -24.51% |
| Sep 30, 2021 | 67.57% |
| Jun 30, 2021 | 114.84% |
| Mar 31, 2021 | -44.15% |
| Dec 31, 2020 | -130.15% |
| Sep 30, 2020 | 26.92% |
| Jun 30, 2020 | -76.09% |
| Mar 31, 2020 | -10.52% |
| Dec 31, 2019 | 30.64% |
| Sep 30, 2019 | -1.83% |
| Jun 30, 2019 | 41.29% |
| Mar 31, 2019 | -102.82% |
| Dec 31, 2018 | -34.98% |
| Sep 30, 2018 | 31.66% |
| Jun 30, 2018 | -35.64% |
| Mar 31, 2018 | -28.88% |
| Dec 31, 2017 | -45.45% |
| Sep 30, 2017 | 28.49% |
| Jun 30, 2017 | 29.67% |
| Mar 31, 2017 | 16.59% |
| Dec 31, 2016 | 163.78% |
| Sep 30, 2016 | 46.69% |
| Jun 30, 2016 | 30.68% |
| Mar 31, 2016 | 31.23% |
| Dec 31, 2015 | 779.39% |
| Sep 30, 2015 | -12.40% |
| Jun 30, 2015 | 44.68% |
| Mar 31, 2015 | 106.39% |
| Dec 31, 2014 | -56.73% |
| Sep 30, 2014 | -81.88% |
| Jun 30, 2014 | 38.89% |
| Mar 31, 2014 | 137.55% |
| Dec 31, 2013 | 57.08% |
| Sep 30, 2013 | -121.74% |